12 AUGUST 2004

NEW ZEALAND GAZETTE, No. 97

per dose unit and not more than 1.2 milligrams per
recommended daily dose except in packs containing
30 micrograms or less of total solanaceous alkaloids

Ibuprofen; for oral use in liquid form in packs containing
not more than 4 grams in medicines which have received
the consent of the Minister or the Director-General to
their sale as pharmacy-only medicines and which are
sold in the manufacturer’s original pack; for oral use in
solid dose form containing not more than 200 milligrams
per dose form in medicines which have received the
consent of the Minister or the Director-General to their
sale as pharmacy-only medicines and which are sold
in the manufacturer’s original pack; except in packs
containing 200 milligrams or less per oral solid dose
form and not more than 25 dose units per pack when
in medicines which have received the consent of the
Minister or the Director-General to their sale as general
sale medicines and which are sold in the manufacturer’s
original pack

Lignocaine; for external use in medicines containing 10% or
less and more than 2%; for urethral use

Minoxidil; for external use in medicines containing 5% or
less

Mometasone; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 200
micrograms and the medicine has received the consent of
the Minister or the Director-General to its distribution as
a pharmacy-only medicine

Nicotine; for inhalation or in lozenges or sublingual tablets
except when sold from a smoking cessation clinic run
under the auspices of a registered medical practitioner,
nurse, pharmacist or psychologist

Nizatidine; in medicines which have received the consent
of the Minister or the Director-General to their sale as
pharmacy-only medicines and which are sold in the
manufacturer’s original pack containing not more than
14 days’ supply

Nystatin; for dermal use

Podophyllum emodi; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin

Podophyllum peltatum; for external use for the treatment
of warts other than anogenital warts in medicines
containing 10% or less of podophyllin

Podophyllotoxin; for external use for the treatment of
warts other than anogenital warts in medicines
containing 0.5% or less

Potassium chlorate; except in medicines containing 10%
or less

Prilocaine; for dermal use in medicines containing 10%
or less

Pyrithione zinc; for external use in medicines containing
more than 2%

Sabadilla; in packs containing 18 milligrams or less of total
alkaloids except in packs containing 1.8 milligrams
or less and a recommended daily dose of not more than
0.6 milligrams of total alkaloids

Silver; except in oral solutions containing 0.3% or less or
other medicines containing 1% or less

Silver sulfadiazine; for external use in packs containing
50 grams or less

Sodium picosulfate; for laxative use

Triamcinolone; in aqueous nasal sprays delivering up to
55 micrograms per actuation when the maximum daily
dose is no greater than 220 micrograms and the medicine
has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

2441

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Acetylcysteine; for external use; for oral use in medicines
containing 1 gram or less per recommended daily dose

Aciclovir; for external use for the treatment of herpes
labialis in medicines containing 5% or less and tubes
containing 3 grams or less

Bamyphylline

Benzamine

Benzyl benzoate

Bifonazole; for external use in medicines for tinea pedis
only or in shampoos containing 1% or less

Butyl aminobenzoate; in medicines for dermal use
containing 2% or less

Collagen; except in injections or implantations for tissue
augmentation or cosmetic use

Dextromethorphan; in liquid form containing 0.25% or less
or in solid dose form containing 15 milligrams or
less per dose form when in packs containing not more
than 600 milligrams and with a recommended daily dose
of not more than 120 milligrams

Dichlofenthion

Diprophylline

Ephedra navadensis

Fluorides; in pastes, gels or powders for cleaning the teeth
containing 0.1% or less; in oral hygiene products
other than pastes, gels or powders for cleaning the
teeth containing 0.01% or less; in parenteral nutrition
replacement preparations; in medicines containing
15 milligrams or less per litre or per kilogram

Folic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose

Folinic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose

Gadobenic acid

Gadobutrol

Guaiphenesin; for oral use in medicines containing 2% or
less or 200 milligrams or less

Hyaluronic acid; except in injections or implantations for
tissue augmentation or cosmetic use

Hydroquinone; for external use in hair preparations
containing 1% or less

Hylan polymer; except in injections or implantations for
tissue augmentation or cosmetic use

Hyoscyamus niger; in packs containing 30 micrograms or
less of total solanaceous alkaloids

Ibuprofen; for external use; for oral use in solid dose form
containing 200 milligrams or less per dose form when in
packs containing not more than 25 dose units and when
in medicines which have received the consent of the
Minister or the Director-General to their sale as general
sale medicines and which are sold in the manufacturer’s
original pack

Injectable medicines; except when specified in the First
Schedule to the Medicines Regulations

Ketoprofen; for external use

Mandelic acid

Monosulfiram

Oxedrine; in medicines containing 30 milligrams or less per
recommended daily dose

Reproterol